×
Remission Rates in Patients With Anxiety Disorders Treated With Paroxetine PDF
$ 40.00
Remission Rates in Patients With Anxiety Disorders Treated With Paroxetine PDF quantity
$ 40.00
×
Suicidal Risk Factors in Bipolar I and II Disorder Patients PDF
$ 40.00
Suicidal Risk Factors in Bipolar I and II Disorder Patients PDF quantity
$ 40.00
×
Early Prediction of Antipsychotic Nonresponse Among Patients With Schizophrenia. PDF
$ 40.00
Early Prediction of Antipsychotic Nonresponse Among Patients With Schizophrenia. PDF quantity
$ 40.00
×
Efficacy, Safety, and Durability of Repeated Ketamine Infusions for Comorbid Posttraumatic Stress Disorder and Treatment-Resistant Depression PDF
$ 40.00
Efficacy, Safety, and Durability of Repeated Ketamine Infusions for Comorbid Posttraumatic Stress Disorder and Treatment-Resistant Depression PDF quantity
$ 40.00
×
Antidepressant-Induced Mania in Bipolar Patients: Identification of Risk Factors PDF
$ 40.00
Antidepressant-Induced Mania in Bipolar Patients: Identification of Risk Factors PDF quantity
$ 40.00
×
Number Needed to Treat to Harm for Discontinuation Due to Adverse Events in the Treatment of Bipolar Depression, Major Depressive Disorder, and Generalized Anxiety Disorder With Atypical Antipsychotics PDF
$ 40.00
Number Needed to Treat to Harm for Discontinuation Due to Adverse Events in the Treatment of Bipolar Depression, Major Depressive Disorder, and Generalized Anxiety Disorder With Atypical Antipsychotics PDF quantity
$ 40.00
×
The Emergence of Social Phobia During Clozapine Treatment and Its Response to Fluoxetine Augmentation PDF
$ 40.00
The Emergence of Social Phobia During Clozapine Treatment and Its Response to Fluoxetine Augmentation PDF quantity
$ 40.00
×
Weight Management Program for Treatment-Emergent Weight Gain in Olanzapine-Treated Patients With Schizophrenia or Schizoaffective Disorder: A 12-Week Randomized Controlled Clinical Trial PDF
$ 40.00
Weight Management Program for Treatment-Emergent Weight Gain in Olanzapine-Treated Patients With Schizophrenia or Schizoaffective Disorder: A 12-Week Randomized Controlled Clinical Trial PDF quantity
$ 40.00
×
Cost-Effectiveness of 12-Month Therapeutic Assertive Community Treatment as Part of Integrated Care Versus Standard Care in Patients With Schizophrenia Treated With Quetiapine Immediate Release (ACCESS Trial) PDF
$ 40.00
Cost-Effectiveness of 12-Month Therapeutic Assertive Community Treatment as Part of Integrated Care Versus Standard Care in Patients With Schizophrenia Treated With Quetiapine Immediate Release (ACCESS Trial) PDF quantity
$ 40.00
×
Accuracy of Self-Reported Weight and Height and Resulting Body Mass Index Among Obese Binge Eaters in Primary Care: Relationship With Eating Disorder and Associated Psychopathology PDF
$ 40.00
Accuracy of Self-Reported Weight and Height and Resulting Body Mass Index Among Obese Binge Eaters in Primary Care: Relationship With Eating Disorder and Associated Psychopathology PDF quantity
$ 40.00
Coupon: Apply coupon
Update cart
